Macrophage LRRK2 hyperactivity impairs autophagy and induces Paneth cell dysfunction

Shengxiang Sun(Washington University in St. Louis), Ta‐Chiang Liu(Washington University in St. Louis), Talin Haritunians(Cedars-Sinai Medical Center), Samuel Ballentine(Washington University in St. Louis), Annie Arguello(Denali Therapeutics (United States)), Anketse Debebe(Icahn School of Medicine at Mount Sinai), Dermot McGovern(Salford Royal NHS Foundation Trust), Nan Gao(Nankai University), Iyshwarya Balasubramanian(Rutgers, The State University of New Jersey), Emebet Mengesha(Cedars-Sinai Medical Center), Inga Peter(Icahn School of Medicine at Mount Sinai), Thaddeus S. Stappenbeck(Cleveland Clinic), Jillian H. Kluss(Denali Therapeutics (United States)), Anthony A. Estrada, Marisa S. Goo(Denali Therapeutics (United States)), Anastasia G. Henry(Denali Therapeutics (United States)), Hoang N. Nguyen(Denali Therapeutics (United States)), Chen‐Ting Hung(Washington University in St. Louis), Atika Malique(Saint Louis University), Michael T. Maloney(Denali Therapeutics (United States)), Justin Kern(Washington University in St. Louis), Uday Pandey(Washington University in St. Louis), Jennifer Frein(Washington University in St. Louis), Miki Hodel(Washington University in St. Louis), Xiang Wang(Denali Therapeutics (United States)), Changqing Ma(Washington University in St. Louis), Javier de Vicente(Tetra Therapeutics (United States)), Maayan Agam(Denali Therapeutics (United States)), Amanda Foster(Washington University in St. Louis), Shaohong Yang(Cedars-Sinai Medical Center)
Science Immunology
November 8, 2024
Cited by 15


Related Papers